Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IDK5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006396 | RNA processing | 6 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0031123 | RNA 3'-end processing | 7 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071076 | RNA 3' uridylation | 8 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 10 |
GO:0016779 | nucleotidyltransferase activity | 4 | 10 |
GO:0050265 | RNA uridylyltransferase activity | 4 | 10 |
GO:0070569 | uridylyltransferase activity | 5 | 10 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 10 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 62 | 66 | PF00656 | 0.521 |
CLV_C14_Caspase3-7 | 83 | 87 | PF00656 | 0.536 |
CLV_NRD_NRD_1 | 270 | 272 | PF00675 | 0.366 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.279 |
CLV_NRD_NRD_1 | 347 | 349 | PF00675 | 0.378 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.451 |
CLV_PCSK_KEX2_1 | 270 | 272 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 291 | 293 | PF00082 | 0.431 |
CLV_PCSK_KEX2_1 | 347 | 349 | PF00082 | 0.378 |
CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.395 |
CLV_PCSK_PC1ET2_1 | 291 | 293 | PF00082 | 0.417 |
CLV_PCSK_PC1ET2_1 | 362 | 364 | PF00082 | 0.440 |
CLV_PCSK_PC1ET2_1 | 91 | 93 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.521 |
CLV_PCSK_SKI1_1 | 377 | 381 | PF00082 | 0.526 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.496 |
DEG_SPOP_SBC_1 | 304 | 308 | PF00917 | 0.665 |
DOC_ANK_TNKS_1 | 346 | 353 | PF00023 | 0.530 |
DOC_MAPK_gen_1 | 353 | 361 | PF00069 | 0.513 |
DOC_MAPK_HePTP_8 | 39 | 51 | PF00069 | 0.492 |
DOC_MAPK_MEF2A_6 | 353 | 361 | PF00069 | 0.519 |
DOC_MAPK_MEF2A_6 | 42 | 51 | PF00069 | 0.473 |
DOC_PIKK_1 | 24 | 32 | PF02985 | 0.370 |
DOC_PP2B_LxvP_1 | 211 | 214 | PF13499 | 0.436 |
DOC_PP4_FxxP_1 | 223 | 226 | PF00568 | 0.405 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.383 |
DOC_USP7_MATH_1 | 305 | 309 | PF00917 | 0.659 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.496 |
DOC_USP7_MATH_1 | 372 | 376 | PF00917 | 0.521 |
DOC_USP7_UBL2_3 | 164 | 168 | PF12436 | 0.332 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.407 |
LIG_14-3-3_CanoR_1 | 270 | 276 | PF00244 | 0.383 |
LIG_14-3-3_CanoR_1 | 303 | 313 | PF00244 | 0.639 |
LIG_Actin_WH2_2 | 236 | 251 | PF00022 | 0.446 |
LIG_AP2alpha_1 | 376 | 380 | PF02296 | 0.501 |
LIG_BRCT_BRCA1_1 | 308 | 312 | PF00533 | 0.651 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.437 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.314 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.493 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.333 |
LIG_FHA_1 | 330 | 336 | PF00498 | 0.464 |
LIG_FHA_1 | 381 | 387 | PF00498 | 0.534 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.555 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.404 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.518 |
LIG_LIR_Apic_2 | 221 | 226 | PF02991 | 0.383 |
LIG_LIR_Gen_1 | 178 | 188 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 252 | 259 | PF02991 | 0.415 |
LIG_LIR_Gen_1 | 274 | 284 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 154 | 159 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 178 | 183 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 205 | 211 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 274 | 279 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 294 | 298 | PF02991 | 0.199 |
LIG_LIR_Nem_3 | 309 | 315 | PF02991 | 0.531 |
LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 337 | 342 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 360 | 364 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 375 | 379 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.360 |
LIG_Pex14_2 | 376 | 380 | PF04695 | 0.401 |
LIG_SH2_CRK | 276 | 280 | PF00017 | 0.450 |
LIG_SH2_GRB2like | 342 | 345 | PF00017 | 0.334 |
LIG_SH2_PTP2 | 159 | 162 | PF00017 | 0.315 |
LIG_SH2_STAP1 | 276 | 280 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 342 | 345 | PF00017 | 0.357 |
LIG_SH3_3 | 169 | 175 | PF00018 | 0.368 |
LIG_SH3_3 | 389 | 395 | PF00018 | 0.603 |
LIG_SUMO_SIM_anti_2 | 189 | 195 | PF11976 | 0.430 |
LIG_SUMO_SIM_anti_2 | 263 | 268 | PF11976 | 0.332 |
LIG_SUMO_SIM_anti_2 | 80 | 86 | PF11976 | 0.506 |
LIG_SUMO_SIM_par_1 | 35 | 41 | PF11976 | 0.455 |
LIG_TRAF2_1 | 316 | 319 | PF00917 | 0.547 |
LIG_TRFH_1 | 223 | 227 | PF08558 | 0.436 |
LIG_WRC_WIRS_1 | 180 | 185 | PF05994 | 0.339 |
LIG_WRC_WIRS_1 | 220 | 225 | PF05994 | 0.492 |
LIG_WRC_WIRS_1 | 399 | 404 | PF05994 | 0.504 |
LIG_WW_1 | 226 | 229 | PF00397 | 0.418 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.565 |
MOD_CK1_1 | 306 | 312 | PF00069 | 0.642 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.356 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.508 |
MOD_CK2_1 | 313 | 319 | PF00069 | 0.574 |
MOD_CK2_1 | 394 | 400 | PF00069 | 0.654 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.506 |
MOD_Cter_Amidation | 3 | 6 | PF01082 | 0.532 |
MOD_Cter_Amidation | 345 | 348 | PF01082 | 0.367 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.413 |
MOD_GlcNHglycan | 294 | 298 | PF01048 | 0.524 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.495 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.551 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.368 |
MOD_GSK3_1 | 303 | 310 | PF00069 | 0.661 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.475 |
MOD_GSK3_1 | 394 | 401 | PF00069 | 0.636 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.470 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.327 |
MOD_N-GLC_1 | 260 | 265 | PF02516 | 0.394 |
MOD_N-GLC_1 | 372 | 377 | PF02516 | 0.506 |
MOD_N-GLC_1 | 73 | 78 | PF02516 | 0.370 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.357 |
MOD_NEK2_1 | 317 | 322 | PF00069 | 0.471 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.561 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.384 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.381 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.266 |
MOD_NEK2_2 | 175 | 180 | PF00069 | 0.460 |
MOD_NEK2_2 | 372 | 377 | PF00069 | 0.489 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.455 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.404 |
MOD_PKA_2 | 352 | 358 | PF00069 | 0.535 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.338 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.366 |
MOD_Plk_1 | 209 | 215 | PF00069 | 0.402 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.504 |
MOD_Plk_1 | 317 | 323 | PF00069 | 0.530 |
MOD_Plk_1 | 372 | 378 | PF00069 | 0.558 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.314 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.488 |
MOD_Plk_4 | 186 | 192 | PF00069 | 0.390 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.332 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.401 |
MOD_SUMO_rev_2 | 355 | 364 | PF00179 | 0.516 |
TRG_DiLeu_BaEn_1 | 106 | 111 | PF01217 | 0.485 |
TRG_DiLeu_LyEn_5 | 106 | 111 | PF01217 | 0.337 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.315 |
TRG_ENDOCYTIC_2 | 208 | 211 | PF00928 | 0.478 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.324 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.356 |
TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.353 |
TRG_ENDOCYTIC_2 | 365 | 368 | PF00928 | 0.472 |
TRG_ER_diArg_1 | 269 | 271 | PF00400 | 0.362 |
TRG_ER_diArg_1 | 347 | 349 | PF00400 | 0.378 |
TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.453 |
TRG_Pf-PMV_PEXEL_1 | 150 | 154 | PF00026 | 0.461 |
TRG_Pf-PMV_PEXEL_1 | 273 | 278 | PF00026 | 0.477 |
TRG_Pf-PMV_PEXEL_1 | 362 | 366 | PF00026 | 0.492 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7H1 | Leptomonas seymouri | 64% | 99% |
A0A0S4J0S6 | Bodo saltans | 56% | 100% |
A0A1X0NX27 | Trypanosomatidae | 55% | 100% |
A0A422NJM7 | Trypanosoma rangeli | 54% | 88% |
A4HYQ1 | Leishmania infantum | 100% | 100% |
C7AJA4 | Trypanosoma brucei brucei | 54% | 100% |
C9ZI80 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9AUK4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QCY0 | Leishmania major | 96% | 100% |
Q6DFA8 | Xenopus laevis | 25% | 80% |